Modulation of brain insulin-like growth factor I (IGF-I) binding sites and hypothalamic GHRH and somatostatin levels by exogenous growth hormone and IGF-I in juvenile rats

Journal of Molecular Neuroscience

Volumn 22, Issue 3, 2004, Pages 179-188

  Eshet, Rina ^a,b   Gil Ad, Irit ^a   Apelboym, Olga ^a   Segev, Yael ^c   Phillip, Moshe ^a,b   Werner, Haim ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

GHRH; Growth hormone; Hypothalamus; IGF I; Igf I receptor; Somatostatin

Indexed keywords

GROWTH HORMONE RELEASING FACTOR; MESSENGER RNA; RECOMBINANT GROWTH HORMONE; RECOMBINANT SOMATOMEDIN C; SODIUM CHLORIDE; SOMATOMEDIN C; SOMATOSTATIN; GROWTH HORMONE; HYBRID PROTEIN; SOMATOMEDIN C RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING SITE; BIOAVAILABILITY; BRAIN LEVEL; BRAIN TISSUE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; EXPERIMENTAL RAT; FROZEN SECTION; HORMONAL REGULATION; HORMONE BINDING; HORMONE DETERMINATION; HYPOPHYSECTOMY; HYPOTHALAMUS; MALE; NEUROMODULATION; NONHUMAN; PROTEIN EXPRESSION; RAT; AGE; ANIMAL; BLOOD; BODY WEIGHT; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; ORGAN SIZE; PHYSIOLOGY; WISTAR RAT;

ANIMALIA;

AGE FACTORS; ANIMALS; BINDING SITES; BODY WEIGHT; GROWTH HORMONE; GROWTH HORMONE-RELEASING HORMONE; HYPOPHYSECTOMY; HYPOTHALAMUS; INSULIN-LIKE GROWTH FACTOR I; MALE; ORGAN SIZE; RATS; RATS, WISTAR; RECEPTOR, IGF TYPE 1; RECOMBINANT FUSION PROTEINS; SOMATOSTATIN;

EID: 2942575813     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1385/JMN:22:3:179     Document Type: Article

References (45)

1. Abe H., Molitch M. E., Van Wyk J. J., and Underwood L. E. (1983) Human growth hormone and somatomedin C suppress the spontaneous release of growth hormone in normal rats. Endocrinology 113, 1319-1325.
2. Adem A., Ekblom J., Gillberg P. G., Jossan S. S., Hoog A., Winblad B., et al. (1994) Insulin-like growth factor I receptors in human spinal cord: changes in amyotrophic lateral sclerosis. J. Neural Transm. Gen. Sect. 97, 73-84.
3. Armstrong C. S., Wuarin-Bierman L., and Ishii D. N. (2000) Uptake of circulating insulin-like growth factor 1 into the cerebrospinal fluid of normal and diabetic rats and normalization of IGF-II mRNA content in diabetic rat brain. J. Neurosci. Res. 59, 649-660.
4. Beck K. D., Powell-Braxton L., Widner H. R., Valverde J., and Hefti F. (1995) IGF-I gene disruption results in reduced brain size, CNS hypomyelinization and loss of hippocampal granule and striatal parvalbumin-containing neurons. Neuron 14, 717-730.
5. Behringer R. R., Lewin T. M., Quaife C. J., Palmiter R. D., Brinster R. L., and D'Ercole A. J. (1990) Expression of insulin-like growth factor I stimulates normal somatic growth in GH-deficient transgenic mice. Endocrinology 127, 1033-1040.
6. Berelowitz M., Firestone S. L., and Frohman L. A. (1981) Effect of GH excess and deficiency on hypothalamic somatostatin content and release and on tissue somatostatin distribution. Endocrinology 109, 714-719.
7. Binoux M. and Hossenlopp P. (1988) Insulin-like growth factor (IGF) and IGF binding proteins: comparison of human serum and lymph. J. Clin. Endocrinol. Metab. 67, 509-514.
8. Bondy C. A. (1991) Transient IGF-I gene expression during the maturation of functionally related central projection neurons. J. Neurosci. 11, 3442-3455.
9. Breier B. H., Gallaher B. W., and Gluckman P. D. (1991) Radioimmunoassay for insulin-like growth factor I: solutions to some potential problems and pitfalls. J. Endocrinol. 128, 347-353.
10. Carro E., Nunez A., Busiguina S., and Tores-Aleman I. (2000) Circulating insulin-like growth factor 1 mediates effects of exercise on the brain. J. Neurosci. 20, 2926-2933.
11. Carson M. J., Behringer R. R., Brinster R. L., and McMorris F. A. (1993) Insulin-like growth factor increases brain growth and central nervous system myelination in transgenic mice. Neuron 10, 729-740.
12. Chung Y. H., Shin C. M., Joo K. M., Kim M. J., and Cha C. I. (2002) Age-related upregulation of insulin-like growth factor receptor type I in rat cerebellum. Neurosci. Lett. 330, 65-68.
13. Daughaday W. H. and Rotwein P. (1989) Insulin-like growth factors I and II, peptide, messenger ribonucleic acid and gene structures, serum and tissue concentrations. Endocr. Rev. 10, 68-91.
14. D'Ercole A. J., Stiles A. D. and Underwood L. E. (1984) Tissue concentrations of somatomedin C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action. Proc. Natl. Acad. Sci. USA 81, 935-939.
15. Dore S., Kar S., and Quirion R. (1997) Rediscovering an old friend, IGF-I: potential use in the treatment of neurodegenerative diseases. Trends Neurosci. 20, 326-331.
16. Dore S., Krieger C., Kar S., and Quirion R. (1996) Distribution and levels of insulin-like growth factor (IGF-I and IGF-II) and insulin receptor binding sites in the spinal cords of amyotrophic lateral sclerosis (ALS) patients. Brain Res. Mol. Brain Res. 96, 128-133.
17. Eshet R., Klinger B., Silbergeld A., and Laron Z. (1993) Modulation of IGF-I receptors by exogenous hGH treatment in constitutionally short children. Clin. Endocrinol. 39, 687-693.
18. Eshet R., Peleg S., Josefsberg Z., Fucks C., Arnon R., and Laron Z. (1984) Some properties of the plasma hGH activity in patients with Laron-type dwarfism determined by radioreceptor assay using human liver tissue. Hormone Res. 22, 276-283.
19. Gerhman J., Yao D. L., Bonetti B., Bondy C. A., Brenner M., Zhou J., et al. (1994) Expression of insulin-like growth factor 1 and related peptides during motoneuron regeneration. Neurology 128, 202-210.
20. Gil-Ad I., Laron Z., and Koch Y. (1991) Effect of acute and chronic administration of clonidine on hypothalamic content of growth hormone releasing hormone and somatostatin in the rat. J. Endocrinol. 131, 381-387.
21. Gil-Ad I., Weizmann A., Silbergeld A., Dickerman Z., Kaplan B., Laron Z., and Koch Y. (1996) Differential effect of insulin-like growth factor I and growth hormone on hypothalamic regulation of growth hormone secretion in the rat. J. Endocrinol. Invest. 19, 542-547.
22. Glasscock G. F., Gelber S. E., Lamson G., McGee-Tekula R., and Rosenfeld R. G. (1990) Pituitary control of growth in the neonatal rat: effects of neonatal hypophysectomy on somatic and organ growth, serum insulin-like growth factor I (IGF-I) and -II levels, and expression of IGF-binding proteins. Endocrinology 127, 1792-1803.
23. Glasscock G. F., Gin K. K. L., Kim J. D., Hintz R. L., and Rosenfeld R. G. (1991) Ontogeny of pituitary regulation of growth in the developing rat: comparison of effects of hypophysectomy and hormone replacement on somatic and organ growth, serum insulin-like growth factor I (IGF-I) and IGF-II levels, and IGF-binding protein levels in the neonatal and juvenile rat. Endocrinology 128, 1036-1047.
24. Gluckman P. D. and Butler A. A. (1994) Endocrine/paracrine interactions following administration of insulin-like growth factor I. Acta Paediatr. Suppl. 399, 180-182.
25. Gosteli-Peter M. A., Winterhalter K. H., Schmid C., Froesch E. R., and Zapf J. (1994) Expression and regulation of insulin-like growth factor I (IGF-I) and IGF-binding protein messenger ribonucleic acid levels in tissues of hypophysectomized rats infused with IGF-I and growth hormone. Endocrinology 135, 2558-2567.
26. Hughes R. A., Sendtner M., and Thoenen H. (1993) Members of several gene families influence survival of rat motoneurons in vitro and in vivo. J. Neurosci. Res. 36, 663-671.
27. Isaksson O. G. P., Kindahl A., Nilsson A., and Isgaard J. (1988) Action of growth hormone: current views. Acta Pediatr. Scand. 343, 12-18.
28. Jones J. I. and Clemmons D. R. (1995) Insulin-like growth factors and their binding proteins: biological actions. Endocr. Rev. 16, 3-34.
29. Katakami H., Downs T. R., and Frohman L. A. (1987) Effect of hypophysectomy on hypothalamic growth hormone releasing factor content and release. Endocrinology 120, 1079-1885.
30. Koch Y. and Baram T. (1976) Convenient procedure for extraction of gonadotropin-releasing hormone and thyrotropin-releasing hormone from hypothalamic tissue. FEBS Lett. 67, 186-191.
31. LeRoith D., Werner H., Faria T.N., Kato H., Adamo M., and Roberts C.T. (1993) Insulin-like growth factor receptors. Implications for nervous system functions. Ann. N. Y. Acad. Sci. 692, 22-32.
32. Liu J. P., Barker J., Perkins A. S., Robertson E. J., and Efstratiadis A. (1993) Mice carrying null mutations on the genes encoding insulin-like growth factor (IGF-I) and type 1IGF receptor (IGF-IR). Cell 75, 59-72.
33. Lowry D. H., Rosenbrough N. J., Farr A. L., and Randall R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 74, 265-275.
34. Moller C., Arner P., Sonnenfeld T., and Norstedt G. (1991) Quantitative comparison of insulin-like growth factor mRNA levels in human and rat tissues analysed by a solution hybridization assay. J. Mol. Endocrinol. 7, 213-222.
35. Neff N. T., Prevette D., Houenou J. L., Lewis M. E., Yin Q. W., and Oppenheim R. W. (1993) Insulin-like growth factors: putative muscle-derived trophic agents that promote motoneuron survival. J. Neurobiol. 24, 1578-1588.
36. Pfaffl M. W., Georgieva T. M., Georgiev I. P., Ontsouka E., Hageleit M., and Blum J. W. (2002) Real-time RT-PCR quantification of insulin-like growth factor I (IGF-I), IGF-I receptor, IGF-2, IGF-2 receptor, insulin receptor, growth hormone receptor, IGF-binding protein 1, 2, and 3 in the bovine species. Domest. Anim. Endocrinol. 22, 91-102.
37. Quaife C. J., Mathews L. S., Pinkert C. A., Hammer R. E., Brinster R. L., and Palmiter R. D. (1989) Histopathology associated with elevated levels of GH and insulin-like growth factor I in transgenic mice. Endocrinology 124, 40-48.
38. Reinhardt R. R. and Bondy C. A. (1994) Insulin-like growth factors cross the blood-brain barrier. Endocrinology 135, 1753-1761.
39. Spencer G. S. G., MacDonald A. A., Battle H. L., Moore L. G., and Carlyle S. S. (1991) Intracerebral administration of insulin like growth factor I decreases circulating GH levels in the fetal pig. Acta Endocrinol. (Copenhagen) 124, 563-570.
40. Wherther G. A., Abate M., Hogg A., Cheesman H., Oldfield B., Hards D., et al. (1990) Localization of insulin-like growth factor 1 mRNA in rat brain by in-situ hybridization-relationship to IGF-I receptors. Mol. Endocrinol. 4, 773-778.
41. Yamaguchi F., Itano T., Mizobuchi M., Miyamoto O., Jajua N. A., Matsu H., et al. (1990) Insulin-like growth factor 1 (IGF-I) distribution in the tissue and extracellular compartment in different regions of rat brain. Brain Res. 533, 344-347.
42. Ye P., Carson M. J. and D'Ercole J. (1995) In vivo actions of insulin-like growth factor-1 (IGF-I) on brain myelination: studies of IGF-I and IGF binding protein-1 (IGFBP-1) in transgenic mice. J. Neurosci. 15, 7344-7356.
43. Zapf J., Hauri C., Waldvogel M., and Froesch E.R. (1986) Acute metabolic effects and half-lives of intravenously administered insulinlike growth factors I and II in normal and hypophysectomized rats. J. Clin. Invest. 77, 1768-1775.
44. Zapf J., Hauri C., Waldvogel M., Futo F., Hasler H., Binz K., et al. (1989) Recombinant human insulin-like growth factor I induces its own specific carrier protein in hypophysectomized and diabetic rats. Proc. Natl. Acad. Sci. U. S. A. 86, 3813-3817.
45. Zhang W., Thornton W. H., Jr., and MacDonald R. (1998) Insulin-like growth factor I and II receptor expression in rat colon mucosa are affected by dietary lipid intake. J. Nutr. 128, 158-165.